Digital dilemma in UK’s life sciences job market
Pharmaceutical Technology
SEPTEMBER 8, 2023
In this issue: Digital jobs in UK life sciences, generative AI changes drug discovery, and how robotics is impacting gene therapy manufacturing.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Pharmaceutical Technology
SEPTEMBER 8, 2023
In this issue: Digital jobs in UK life sciences, generative AI changes drug discovery, and how robotics is impacting gene therapy manufacturing.
Pharma Times
APRIL 17, 2024
Both companies will facilitate career progression while advancing the life sciences industry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
APRIL 17, 2024
The European Laboratory Research & Innovation Group (ELRIG) UK has entered into a partnership with SRG to support the advancement of science professionals in their careers. Sanj Kumar, CEO, ELRIG UK, said: “ELRIG and SRG have a shared ambition to advance the careers of early-stage professionals in drug discovery.
pharmaphorum
JANUARY 25, 2024
Discover the role of GenAI in life sciences in 2024. Explore how artificial intelligence and machine learning techniques like GenAI are revolutionising drug development, diagnostics, and research. Learn how industry leaders, including Google, are leveraging GenAI to advance healthcare and enhance patient outcomes.
XTalks
JANUARY 24, 2024
In this episode, Ayesha talked about some of the trends in the life sciences to watch out for in 2024. Hear about the latest technologies and approaches that will help drive innovations in drug discovery, clinical research and medical device design this year.
XTalks
JANUARY 31, 2024
Skye Bioscience is at the forefront of exploring the endocannabinoid system for drug development. Punit Dhillon, Chairman & CEO Skye Bioscience Punit brings two decades of experience as a leader and investor within the life sciences sector. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.
Bio Pharma Dive
MAY 15, 2024
Elsewhere, ICER is raising questions about a PTSD drug and BioMarin is cut jobs after a pipeline review. The parent of Novo Nordisk is acquiring 60% ownership of Single Use Support.
pharmaphorum
FEBRUARY 29, 2024
Explore the impact of the Inflation Reduction Act (IRA) on drug prices and negotiations within the life sciences industry, as it stands on the threshold of change. Gain insights into the potential outcomes and implications of this legislation.
Cloudbyz
MARCH 17, 2024
In the dynamic world of life sciences, where innovation is paramount, the integration of cutting-edge technologies is crucial for accelerating clinical operations and driving breakthroughs in healthcare. Salesforce’s recent announcement of its Life Sciences Cloud marks a significant stride towards this goal.
Pharmaceutical Technology
NOVEMBER 8, 2022
Viatris has signed definitive agreements to acquire Oyster Point Pharma and Famy Life Sciences in a deal totalling nearly $700m-$750m in cash to establish an ophthalmology franchise. Oyster Point Pharma introduced Tyrvaya, a nasal spray approved by the Food and Drug Administration (FDA) to treat dry eye disease, in November last year.
Drug Discovery World
MARCH 20, 2024
Bruntwood SciTech and Thermo Fisher Scientific have entered into a new strategic collaboration to support businesses across Bruntwood SciTech’s national portfolio of life science campuses, with a particular focus at their Alderley Park campus in Cheshire – the UK’s largest single site life science campus, which is home to more than 250 science and (..)
XTalks
SEPTEMBER 12, 2023
Life science podcasts have emerged as an invaluable tool for building connections with audiences in the digital era. Furthermore, we’ll explore the unique advertising opportunities that this platform offers, positioning brands at the forefront of the life science industry. The result?
Pharmaceutical Technology
JUNE 2, 2023
Anavex Life Sciences has secured new US intellectual property compositions patent for its ANAVEX 2-73 (blarcamesine). Anavex’s orally available drug candidate restores cellular homeostasis by targeting sigma-1 and M1 muscarinic receptors.
Pharmaceutical Technology
JUNE 16, 2023
for an undisclosed sum, boosting its life science AI capabilities. The deal enables Verix to further improve its capacities to use AI to advance the brand growth of life science companies. Artificial intelligence (AI)-driven commercial optimisation platform provider Verix has purchased start-up.ai start-up.ai
XTalks
FEBRUARY 14, 2023
The life science industry is constantly evolving, making it difficult to stay ahead of the curve. There’s no doubt that pharmaceutical and biotechnology organizations are utilizing innovative technology solutions across all sectors of drug development, research and development, supply chain, manufacturing and more.
XTalks
DECEMBER 20, 2023
As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables.
Pharmaceutical Technology
SEPTEMBER 15, 2022
From the Human Genome Project to contemporary drug development, collaboration is critical to the life sciences. It is also an important factor in the success of life sciences clusters, where a high concentration of pharmaceutical or medical device companies can all be found in one district, city or region.
XTalks
MARCH 20, 2024
In this featured episode of Xtalks People in Life Sciences, Ayesha spoke with Ashish Jain, Senior Director of Clinical Safety and Pharmacovigilance (PV) at Curis , a pioneering biotech company specializing in cutting-edge cancer therapies. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.
Drug Discovery World
APRIL 17, 2024
Bios Health Group has launched the Bios Innovation Circle – a new venture studio and strategic hub, designed to support biotechnology and life science companies towards growing success. A real revolution in life science development.”
Drug Channels
MARCH 18, 2024
Informa Connect’s Life Sciences Pricing & Contracting USA May 21-23, 2024 | New Orleans Drug Channels readers save 10% with code 24DRCH10* Whether your daily focus is on Medicaid, Government Pricing, 340B, Drug Price Transparency, Commercial Contracting or Chargebacks , we have you covered! All rights reserved.
Cloudbyz
MAY 17, 2024
This Act is poised to significantly change the clinical trials landscape within the life sciences sector. As AI increasingly becomes a cornerstone in clinical research and drug development, it is crucial for industry stakeholders to grasp the extensive implications of this regulation. first appeared on CLOUDBYZ.
Drug Discovery World
JANUARY 30, 2023
DDW Editor Reece Armstrong takes a look at Lithuania’s life sciences sector and what it means for start-ups operating in the country. Despite consisting of largely small enterprises, Lithuania is still home to some large players in the life sciences sector including Thermo Fisher Scientific, Teva and Northway Biotech.
XTalks
SEPTEMBER 6, 2023
David Young, founder and President R&D at Processa Pharmaceuticals, a clinical-stage pharmaceutical company developing personalized approaches to cancer treatments with a focus on next generation chemotherapy drugs with improved safety and efficacy. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.
Drug Discovery World
MARCH 15, 2024
Valneva Scotland scooped two prizes at Scotland’s Life Sciences Awards 2024, including the award for Innovation – Pharma Services And Drug Discovery, in a ceremony on 14 March in Glasgow. billion of contribution to the Scottish economy, the success of the life sciences sector is phenomenal.
Pharmaceutical Technology
DECEMBER 14, 2022
GSK has entered a strategic partnership with Wave Life Sciences to progress the discovery and development of oligonucleotide therapies for new genetic targets. Wave will conduct all preclinical research for the programmes of both companies until investigational new drug (IND)-facilitating studies. .
Bio Pharma Dive
JUNE 15, 2022
The fund, Third Rock’s sixth, comes amid a significant downturn in the biotech stock market, which has raised questions about the viability of young drug startups.
XTalks
MAY 29, 2024
Cocrystal Pharma leverages a unique structure-based drug discovery platform, complemented by Nobel Prize-winning expertise, to develop leading-edge antiviral drugs that are both first-in-class and best-in-class. Dr. Lee brings over 25 years of experience in anti-infective drug discovery research to his role.
Drug Discovery World
OCTOBER 31, 2023
PwC has published a new report on the UK life sciences industry ‘The Life Sciences Future50’, highlighting companies that illustrate world-class science and innovation, including 32 in the therapeutics space. According to the report, the life science industry represents a £43.4 ($52.7)
XTalks
JANUARY 4, 2023
In this episode, Ayesha talked about some of the trends to look out for in the life sciences in 2023. Also hear about the issue of drug shortages and how pharma companies hope to tackle it in 2023. Read the full article here: 4 Life Sciences Trends for 2023.
Drug Discovery World
MARCH 7, 2023
For International Women’s Day, DDW’s Diana Spencer celebrates some of the women in leadership making an impact on the drug discovery and life sciences sector. The life sciences sector has traditionally outperformed others when it comes to attracting women to its workforce.
Drug Discovery World
JULY 14, 2023
International investors are abandoning UK life sciences as excessive revenue clawback rates start to bite, according to the latest Life Sciences Competitiveness Indicators published by the government 1. While this drop is in part due to the pandemic related spike in life sciences investment in 2020 and 2021, the £7.1
Pharmaceutical Technology
JUNE 20, 2023
Most of us have heard of ChatGPT and AI but where and how do they fit into the life sciences ecosystem? AI-powered solutions in healthcare While the impact of AI will be far-reaching, its pattern-matching abilities and processing speed means AI has the potential to revolutionise the field of life sciences and medicine, in particular.
XTalks
FEBRUARY 22, 2022
A successful life science webinar engages the audience in a unique manner, drives the right kind of traffic and provides genuine value for attendees. Here are 5 trending life science webinar topics that have been resonating well with our audiences. Then view our past life science webinars here.
Drug Discovery World
SEPTEMBER 4, 2023
The Innovation Centre has enabled the rapid growth of the life sciences hub at Canary Wharf , providing opportunities for early-stage life science companies to collaborate and innovate. Edited by Diana Spencer, Senior Digital Content Editor, Drug Discovery World Image shows: Canary Wharf, London, UK.
XTalks
DECEMBER 20, 2023
In 2023, there were significant advancements and notable trends in the life sciences. These advancements and trends addressed important industry challenges and offered opportunities to foster innovations and solutions in areas including drug development, healthcare and medical devices.
Drug Discovery World
MAY 9, 2023
Cytiva and the life sciences business of Pall Corporation have completed their integration and are now united as one business under the Cytiva brand. In January 2023, the life sciences business of Pall separated from Pall Corporation. Pall’s biotech portfolio is now a product family in Cytiva’s bioprocess business.
Drug Discovery World
DECEMBER 13, 2023
This article is sponsored by Fortis Life Sciences. Antibodies are used as therapeutics, components of therapeutics such as antibody-drug conjugates (ADC) and CAR-T cells, and as companion diagnostic tools. In the ever-evolving landscape of therapeutic development, the role of antibodies has become increasingly apparent.
Drug Discovery World
MARCH 20, 2023
The resulting new Life Sciences and Diagnostics business will share the PerkinElmer name until a new name, brand and ticker symbol is unveiled in Q2 2023 pending shareholder approval. Within Life Sciences, the company is focused on supporting pharmaceutical and academic scientific advancement from the earliest stage of discovery.
Drug Discovery World
DECEMBER 4, 2023
The University of Glasgow and Kadans Science Partner, supported by Scottish Enterprise, have announced plans to construct a new Health Innovation Hub in Govan in Glasgow. It is hope that the new centre, which is due for completion in summer 2025, will set the stage for a thriving life sciences cluster in the area.
Drug Discovery World
FEBRUARY 6, 2024
Richard Torbett, Chief Executive of the ABPI said: “The UK’s life sciences industry can deliver the jobs and growth the country needs, while also transforming NHS health outcomes and boosting British scientific research. The post The ABPI sets out a manifesto for UK life sciences appeared first on Drug Discovery World (DDW).
XTalks
FEBRUARY 15, 2023
Bastiaan Driehuys, PhD Founder and Chief Technology Officer Polarean Imaging plc In this week’s Xtalks Life Science podcast episode, Ayesha and the editorial team spoke with Dr. Bastiaan Driehuys, Founder and Chief Technology Officer at Polarean Imaging plc. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.
Drug Discovery World
JULY 4, 2023
Vesalius Biocapital, a life sciences venture capital investor, has closed its fourth fund, Vesalius Biocapital IV, securing over €95 million of commitments. The company plans to invest in first and best-in-class European life science companies in drug development and digital health.
Drug Channels
MARCH 28, 2024
Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Bill discusses specialty therapy access barriers, including payer utilization management techniques and “no coverage” policies. Contact Mercalis to learn about their Patient Support Services. Read on for Bill’s insights. All rights reserved.
XTalks
AUGUST 23, 2023
Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Williams about BriaCell’s novel cell therapies for cancer and what the future of immunotherapy and personalized treatments may look like.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content